Viewing StudyNCT00522938



Ignite Creation Date: 2024-05-05 @ 6:39 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00522938
Status: TERMINATED
Last Update Posted: 2012-06-28
First Post: 2007-08-29

Brief Title: Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Sponsor: Chroma Therapeutics
Organization: Chroma Therapeutics

Organization Data

Organization: Chroma Therapeutics
Class: INDUSTRY
Study ID: CHR-2797-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Chroma Therapeutics
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators